Ausgabe 1/2010
Special Issue on Economic Evaluation
Inhalt (11 Artikel)
HTA in Germany: very special and specific
Wolfgang Greiner, J.-Matthias Graf von der Schulenburg
On the welfare theoretic foundation of cost-effectiveness analysis—the case when survival is not affected
Bengt Liljas
Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approach
Jan Steffen Jürgensen, Wolfgang Arns, Bastian Haß
Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study
Feng Xie, Ngai-Nung Lo, Jean-Eric Tarride, Daria O’Reilly, Ron Goeree, Hin-Peng Lee
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
Montserrat Vera-Llonch, Ellen Dukes, Javier Rejas, Oleg Sofrygin, Marko Mychaskiw, Gerry Oster
The added value of thorough economic evaluation of telemedicine networks
Myriam Le Goff-Pronost, Claude Sicotte
An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis?
Rachel A. Elliott, Helen L. A. Weatherly, Neil S. Hawkins, Gillian Cranny, Duncan Chambers, Lindsey Myers, Alison Eastwood, Mark J. Sculpher
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis
Yogesh Suresh Punekar, Neil Hawkins
Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings
Harald J. Hamre, Claudia M. Witt, Anja Glockmann, Renatus Ziegler, Gunver S. Kienle, Stefan N. Willich, Helmut Kiene
Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure
Sonja Merkesdal, Timm Kirchhoff, Diane Wolka, Gunter Ladinek, Adrian Kielhorn, Andrea Rubbert-Roth
Cost effectiveness of palivizumab in Spain: an analysis using observational data
Mark J. Nuijten, Wolfgang Wittenberg